2001
DOI: 10.1038/emm.2001.2
|View full text |Cite
|
Sign up to set email alerts
|

Detection of circulating tumor cells in patients with gastrointestinal tract cancer using RT-PCR and its clinical implications

Abstract: To investigate the relationship between the presence of circulating tumor cells in different stages of gastrointestinal tract cancer and the subsequent relapse or distant metastasis, circulating levels of CEA mRNA was serially examined at an interval of 10.6 ± 4.5 or 13.7 ± 3.0 months in gastric or colorectal cancer patients, respectively.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

1
8
0

Year Published

2002
2002
2021
2021

Publication Types

Select...
7

Relationship

0
7

Authors

Journals

citations
Cited by 18 publications
(9 citation statements)
references
References 24 publications
1
8
0
Order By: Relevance
“…In the literature, the presence of CTCs in the peripheral blood has been reported to be associated with malignant biological properties, more advanced disease and poor prognosis of GC patients. [12][13][14]30 Similarly, our results showed that the frequency of hTERT, CK-19, CEA and MUC1 mRNA overexpression were significantly higher in advanced GC patients (82.8-87.9%) than in patients with early stage GC (33.3-50%). Moreover, the detection rates for CTCs in GC patients by using single markers CK-19, CEA or MUC1 mRNA were prominently higher in GC patients with stage III and IV GC than in patients with stage I and II GC.…”
Section: Discussionsupporting
confidence: 53%
See 1 more Smart Citation
“…In the literature, the presence of CTCs in the peripheral blood has been reported to be associated with malignant biological properties, more advanced disease and poor prognosis of GC patients. [12][13][14]30 Similarly, our results showed that the frequency of hTERT, CK-19, CEA and MUC1 mRNA overexpression were significantly higher in advanced GC patients (82.8-87.9%) than in patients with early stage GC (33.3-50%). Moreover, the detection rates for CTCs in GC patients by using single markers CK-19, CEA or MUC1 mRNA were prominently higher in GC patients with stage III and IV GC than in patients with stage I and II GC.…”
Section: Discussionsupporting
confidence: 53%
“…To date, several tumor-associated mRNA markers have been demonstrated to be absent in normal cells but overexpressed in GC cells, for example, human telomerase reverse transcriptase (hTERT), cytrokeratin-19 (CK-19), carcinoembryonic antigen (CEA) and mucin 1 (MUC1). [12][13][14][15][16] These mRNA markers have been extensively tested for their application to the detection of circulating tumor cells (CTCs) in GC patients.…”
mentioning
confidence: 99%
“…To confirm the differential expressions of genes screen-ed by DNA chip analysis, RT-PCR was performed (Noh et al, 2001). To synthesize first strand cDNA, one microgram of RNA and 1 µl of 10 µM oligodT (T25NN) were mixed to a final reaction volume of 5 µl and heated for 2 min at 72 o C. After cooling on ice for 2 min, RT was performed for 2 h at 42 o C in a 10 µl reaction mixture containing 50 mM Tris-HCl, pH 8.3, 75 mM KCl, 6 mM MgCl2, 2 mM DTT, 1 mM dNTP mix and 200 units MMLV reverse transcriptase.…”
Section: Reverse Transcription-polym Erase Chain Reaction (Rt-pcr)mentioning
confidence: 99%
“…Total RNA was isolated from the human spermatozoa using the guanidinium thiocyanate-phenol extraction (Chomczynski and Sacchi, 1987;Noh et al, 2001), which was repeated at least 3 times to improve the quality of sperm RNA.…”
Section: Aterials and M Ethodsmentioning
confidence: 99%